Human medicines European public assessment report (EPAR): Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune), pandemic influenza vaccine (H5N1) (live attenuated, nasal), Date of authorisation: 20/05/2016, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Rizmoic, naldemedine, Date of authorisation: 18/02/2019, Revision: 13, Status: Authorised

Article 57 product data

Human medicines European public assessment report (EPAR): Esbriet, pirfenidone, Date of authorisation: 27/02/2011, Revision: 36, Status: Authorised

List of medicinal products under additional monitoring

List of medicinal products under additional monitoring

Dextrans - Scientific guideline

EMA/PE/0000182447

EMA/PE/0000183373

EMA/PE/0000183329